We’re diving deep into the transformative power of AI in healthcare. Sessions will explore the responsible integration of AI into regulated digital health solutions, with a focus on cardiometabolic care, and showcase how generative AI is revolutionizing drug discovery, clinical trials, and commercialization in pharma.

Attendees will also engage in a hands-on workshop to learn how AI and machine learning can drive insights, streamline operations, and enhance strategies across various organizational functions and much much more.

Here are a few of the can’t-miss sessions

AI in Digital Health: Pathways to responsibly integrating AI into regulated solutions [Keynote]

Anand Iyer - Chief AI Officer, Welldoc

LEARN MORE

Transforming the pharma commercial model with AI [Deep Dive]

• Scott Snyder - Chief Digital Officer, EVERSANA
• Alyssa Fenoglio - Vice President, Global Head of Digital Commercial, Teva
• Gautam Gupta - Head of Strategy & Consulting, Pfizer 
• Kimberly Noel - Global Heal of AI Advocacy & Digital Health, Roche

LEARN MORE

No good data - no good AI solutions. Is the European Health Data Space (EHDS) a gamechanger for startups developing medical algorithms in Europe? [Deep Dive]

• Artur Olesch - Founder & Editor-in-Chief, aboutDigitalHealth.com
• Simon Rost - Global Chief Marketing and Strategy Officer, GE HealthCare
• Andrzej Rys - Principal Scientific Advisor, DG Health and Food Safety (SANTE), European Commission
• Nora Sagel - Managing Director, Honic

LEARN MORE

Data and AI to speed up the R&D process and improve the probability of success and pharma R&D’s ROI – real world use cases by Orion Pharma, Finland [Deep Dive]

• Sammeli Liikkanen - Director of Digital Medicine, Orion Pharma
• Julius Sipilä - Discovery Data Technology Lead, Orion Pharma
• Jean-Philippe Theurillat - Group Leader Institute of Oncology Research, Bellinzona & Associate Professor, Faculty of Biomedical Sciences, University of Southern Switzerland (USI), Lugano
• Jerome Windsor - SVP BD and Strategic Alliances, AITIA Bio

LEARN MORE

AI and Pricing and Market Access [Masterclass]

Alan Crowther - General Manager, Global Pricing & Access, EVERSANA

LEARN MORE

Predictive ML model to select patients with diabetes and COPD needing continuous EKG monitoring to reduce clinical and economic disease burden: A Real-World Study. [Deep Dive]

• Pierantonio Russo - Corporate Chief Medical Officer, EVERSANA
• Brent Wright - Sr. Director of Value and Access Transformation, iRhythm Technologies

LEARN MORE

Putting AI and Machine Learning Into Practice: Explore the Power to Drive Better Outcomes [Hands-on Workshop]

This hands-on workshop will provide insights into adopting and leveraging GenAI solutions to address existing challenges, fill data gaps, improve processes, and expedite time to market. 

Abid Rahman - Senior Vice President, Innovation, EVERSANA

LEARN MORE

AI in Drug Discovery and Impacts of AI Act in Europe

You’ll find more insights and real world applications of AI in numerous other sessions throughout the two day conference. Including insightful talks in our Science Track , entitled “From Campus to Bedside and Beyond: Strategies for Tomorrow’s Biomedical Breakthroughs”. This will include contributions from Owkin on how they are combining human expertise and AI to deliver better drugs and diagnostics at scale and how Verseon is leveraging quantum physics modeling to enhance R&D processes. We will also be covering the policy implications of AI during the session entitled “The European Health Data Space and the AI Act: Insights and Implications for Health Innovation” during our Digital Health Policy Summit 2024.

More great sessions will be announced soon, you can always search “AI” in the main agenda to sort all sessions around this theme at anytime.

EXPLORE THE FULL AGENDA

Join us in Berlin on October 17-18, 2024, and register here!